Page values for "Ipilimumab"
Jump to navigation
Jump to search
"_pageData" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| _pageID | Integer | 859,938 |
| _pageName | Page | Ipilimumab |
| _pageTitle | String | Ipilimumab |
| _pageNamespace | Integer | 0 |
"definitions" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| Term | Page | Ipilimumab |
| Short_definition | String | ipilimumab (ih-pih-LIH-myoo-mab) A drug that binds to the protein CTLA-4 to help immune cells kill cancer cells better, and is used to treat many different types types of cancer is used. These include cancers that have certain mutations (changes) in genes involved in DNA repair. |
| Type | Page | Cancer terms |
| Specialty | Page | Oncology |
| Language | Page | English |
| Source | Page | NCI |
| Comments | String |